These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36634035)

  • 1. Natural product ligands of FKBP12: Immunosuppressive antifungal agents FK506, rapamycin, and beyond.
    Rivera A; Heitman J
    PLoS Pathog; 2023 Jan; 19(1):e1011056. PubMed ID: 36634035
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor.
    Bastidas RJ; Shertz CA; Lee SC; Heitman J; Cardenas ME
    Eukaryot Cell; 2012 Mar; 11(3):270-81. PubMed ID: 22210828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506-binding protein 12 ligands: a patent review.
    Liu F; Wang YQ; Meng L; Gu M; Tan RY
    Expert Opin Ther Pat; 2013 Nov; 23(11):1435-49. PubMed ID: 23957229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR.
    Cruz MC; Goldstein AL; Blankenship J; Del Poeta M; Perfect JR; McCusker JH; Bennani YL; Cardenas ME; Heitman J
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3162-70. PubMed ID: 11600372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in
    Ianiri G; Applen Clancey S; Lee SC; Heitman J
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Guided Synthesis of FK506 and FK520 Analogs with Increased Selectivity Exhibit
    Hoy MJ; Park E; Lee H; Lim WY; Cole DC; DeBouver ND; Bobay BG; Pierce PG; Fox D; Ciofani M; Juvvadi PR; Steinbach W; Hong J; Heitman J
    mBio; 2022 Jun; 13(3):e0104922. PubMed ID: 35604094
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Lee Y; Lee KT; Lee SJ; Beom JY; Hwangbo A; Jung JA; Song MC; Yoo YJ; Kang SH; Averette AF; Heitman J; Yoon YJ; Cheong E; Bahn YS
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of FKBP12/12.6 from endothelial ryanodine receptors leads to an intracellular calcium leak and endothelial dysfunction.
    Long C; Cook LG; Wu GY; Mitchell BM
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1580-6. PubMed ID: 17478757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506.
    Xu X; Su B; Barndt RJ; Chen H; Xin H; Yan G; Chen L; Cheng D; Heitman J; Zhuang Y; Fleischer S; Shou W
    Transplantation; 2002 Jun; 73(11):1835-8. PubMed ID: 12085010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK506 binding proteins as targets in anticancer therapy.
    Romano S; Di Pace A; Sorrentino A; Bisogni R; Sivero L; Romano MF
    Anticancer Agents Med Chem; 2010 Nov; 10(9):651-6. PubMed ID: 21182472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans.
    Arndt C; Cruz MC; Cardenas ME; Heitman J
    Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():1989-2000. PubMed ID: 10463165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents.
    Juvvadi PR; Fox D; Bobay BG; Hoy MJ; Gobeil SMC; Venters RA; Chang Z; Lin JJ; Averette AF; Cole DC; Barrington BC; Wheaton JD; Ciofani M; Trzoss M; Li X; Lee SC; Chen YL; Mutz M; Spicer LD; Schumacher MA; Heitman J; Steinbach WJ
    Nat Commun; 2019 Sep; 10(1):4275. PubMed ID: 31537789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A calcineurin antifungal strategy with analogs of FK506.
    Nambu M; Covel JA; Kapoor M; Li X; Moloney MK; Numa MM; Soltow QA; Trzoss M; Webb P; Webb RR; Mutz M
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2465-2471. PubMed ID: 28412204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging Fungal and Human Calcineurin-Inhibitor Structures, Biophysical Data, and Dynamics To Design Selective and Nonimmunosuppressive FK506 Analogs.
    Gobeil SM; Bobay BG; Juvvadi PR; Cole DC; Heitman J; Steinbach WJ; Venters RA; Spicer LD
    mBio; 2021 Dec; 12(6):e0300021. PubMed ID: 34809463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
    Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
    Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis of Nonimmunosuppressive FK506 Analogues with Antifungal Activity.
    Beom JY; Jung JA; Lee KT; Hwangbo A; Song MC; Lee Y; Lee SJ; Oh JH; Ha SJ; Nam SJ; Cheong E; Bahn YS; Yoon YJ
    J Nat Prod; 2019 Aug; 82(8):2078-2086. PubMed ID: 31321978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein.
    Odom A; Del Poeta M; Perfect J; Heitman J
    Antimicrob Agents Chemother; 1997 Jan; 41(1):156-61. PubMed ID: 8980772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
    Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
    Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin).
    High KP; Washburn RG
    J Infect Dis; 1997 Jan; 175(1):222-5. PubMed ID: 8985226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK506-binding protein (FKBP12) regulates ryanodine receptor-evoked Ca2+ release in colonic but not aortic smooth muscle.
    MacMillan D; Currie S; McCarron JG
    Cell Calcium; 2008 Jun; 43(6):539-49. PubMed ID: 17950843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.